Back to Search Start Over

Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.

Authors :
Mannstadt, Michael
Clarke, Bart L
Bilezikian, John P
Bone, Henry
Denham, Douglas
Levine, Michael A
Peacock, Munro
Rothman, Jeffrey
Shoback, Dolores M
Warren, Mark L
Watts, Nelson B
Lee, Hak-Myung
Sherry, Nicole
Vokes, Tamara J
Source :
The Journal of Clinical Endocrinology & Metabolism; November 2019, Vol. 104 Issue: 11 p5136-5147, 12p
Publication Year :
2019

Abstract

Conventional hypoparathyroidism treatment with oral calcium and active vitamin D is aimed at correcting hypocalcemia but does not address other physiologic defects caused by PTH deficiency.

Details

Language :
English
ISSN :
0021972X and 19457197
Volume :
104
Issue :
11
Database :
Supplemental Index
Journal :
The Journal of Clinical Endocrinology & Metabolism
Publication Type :
Periodical
Accession number :
ejs52106399
Full Text :
https://doi.org/10.1210/jc.2019-01010